Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenomics in Insulin Resistance Associated Overactive Bladder.

NCT03057158 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03057158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03057158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenomics in Insulin Resistance Associated Overactive Bladder.
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
May 1, 2017
Completion date
March 11, 2020
Enrollment
257 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, overactive bladder